Taxonomy of Observational Study Designs - Phase 2

Project Title Taxonomy of Observational Study Designs - Phase 2
Date Posted
Monday, April 9, 2012
Status
Complete
Deliverables
Description

Phase 2 of a methods project 1) to create a decision table that enables expedited matching of medical product safety questions to design and analytic approaches and 2) to map recommended statistical methods to the epidemiologic designs delineated in Phase 1.

Workgroup Leader(s)

Joshua Gagne PharmD, ScD; Sebastian Schneeweiss MD, ScD; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA

Workgroup Members

Bruce Fireman MA; Kaiser Permanente Northern California, Oakland, CA

Tobias Gerhard PhD; Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ

Jennifer Nelson PhD; Biostatistics Unit, Group Health Research Institute and Department of Biostatistics, University of Washington, Seattle, WA

John Seeger PharmD, DrPH; Jeremy Rassen ScD; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA

Azadeh Shoaibi MS, MHS; Marsha Reichman PhD; Office of Medical Policy, Center for Drug Evaluation and Research, FDA, Silver Spring, MD

Darren Toh ScD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Department of Population Medicine and Harvard Medical School, Boston, MA

Related Links